Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01087333 · ClinicalTrials.gov registry record

Collection of Human Samples to Study Hairy Cell and Other Leukemias, and to Develop Recombinant Immunotoxins for Cancer Treatment

A clinical trial of Chronic Lymphocytic Leukemia (CLL) and Non-Hodgkins Lymphoma (NHL), sponsored by National Cancer Institute (NCI).

Recruiting
Registry status
1,263
Enrollment target
1
Study location

NCT01087333 is a study of Chronic Lymphocytic Leukemia (CLL) and Non-Hodgkins Lymphoma (NHL) that is actively recruiting participants, run by National Cancer Institute (NCI). The registered enrollment target is 1,263 participants, above the 148-participant average among 29 other Chronic Lymphocytic Leukemia (CLL) trials with a reported enrollment target (753% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01087333, a study of Chronic Lymphocytic Leukemia (CLL) and Non-Hodgkins Lymphoma (NHL), is actively recruiting participants, sponsored by National Cancer Institute (NCI).

RECRUITING
Registry status
1,263 participants
Enrollment target
1
Study location

Study Summary

Background: \- Researchers who are studying hairy cell leukemia, and how the disease compares with other disorders, are interested in obtaining additional samples from leukemia patients and healthy volunteers. The investigators are particularly interested in samples from individuals who have diseases that can be treated with a new type of drug called immunotoxin, in which an antibody carrying a toxin binds to a cancer cell and allows the toxin to kill the cell. Objectives: \- To collect a variety of clinical samples, including blood, urine, lymph samples, and other tissues, in order to study the samples and develop new treatments for leukemia. Eligibility: \- Individuals 18 years of age and older who have been diagnosed with leukemia or other kinds of blood and lymphatic system cancers, or who are healthy volunteers. Design: * Individuals who have leukemia will be asked to provide blood, bone marrow, urine, and tumor tissue samples as requested by the researchers. Healthy volunteers will provide only blood and urine samples. * No treatment will be given as part of this protocol.

Conditions Studied

Chronic Lymphocytic Leukemia (CLL) Non-Hodgkins Lymphoma (NHL) Cutaneous T Cell Lymphoma (CTCL) Hairy Cell Leukemia (HCL) Adult T Cell Lymphoma (ATL)

Study Locations (1)

Maryland

  • National Institutes of Health Clinical Center - Bethesda

Trial Details

FieldValue
Enrollment Target 1,263 participants
Start Date 2010-03-02

Sponsor

National Cancer Institute (NCI)

3,257 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT01087333

The ClinicalTrials.gov registry entry for NCT01087333 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 1,263 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 148-participant average among 29 other Chronic Lymphocytic Leukemia (CLL) trials with a reported enrollment target (753% higher). The listed sponsor is National Cancer Institute (NCI), which has 3,257 total studies on file at ClinicalTrials.gov.

The record links to 5 conditions, with Chronic Lymphocytic Leukemia (CLL) appearing as the primary indexed condition, and to 0 interventions.

NCT01087333 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.

Frequently Asked Questions

What is clinical trial NCT01087333 about?

NCT01087333 is a clinical study titled "Collection of Human Samples to Study Hairy Cell and Other Leukemias, and to Develop Recombinant Immunotoxins for Cancer Treatment". Background: \- Researchers who are studying hairy cell leukemia, and how the disease compares with other disorders, are interested in obtaining additional samples from leukemia patients and healthy volunteers. The investigators are particularly interested in samples from individuals who have diseas...

What is the current status of trial NCT01087333?

This trial is currently recruiting. The enrollment target is 1,263 participants. The study started on 2010-03-02.

What conditions does trial NCT01087333 study?

This clinical trial studies the following conditions: Chronic Lymphocytic Leukemia (CLL), Non-Hodgkins Lymphoma (NHL), Cutaneous T Cell Lymphoma (CTCL), Hairy Cell Leukemia (HCL), Adult T Cell Lymphoma (ATL).

Who is sponsoring clinical trial NCT01087333?

This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01087333 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Chronic Lymphocytic Leukemia (CLL)

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Chronic Lymphocytic Leukemia (CLL)

All registered trials for this condition

Non-Hodgkins Lymphoma (NHL)

All registered trials for this condition

Maryland

All trials with a study site in Maryland

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.